SARS-CoV-2 infection (intraventricular)

ES Eric Song
CZ Ce Zhang
BI Benjamin Israelow
AL Alice Lu-Culligan
AP Alba Vieites Prado
SS Sophie Skriabine
PL Peiwen Lu
OW Orr-El Weizman
FL Feimei Liu
YD Yile Dai
KS Klara Szigeti-Buck
YY Yuki Yasumoto
GW Guilin Wang
CC Christopher Castaldi
JH Jaime Heltke
EN Evelyn Ng
JW John Wheeler
MA Mia Madel Alfajaro
EL Etienne Levavasseur
BF Benjamin Fontes
NR Neal G. Ravindra
DD David Van Dijk
SM Shrikant Mane
MG Murat Gunel
AR Aaron Ring
SK Syed A. Jaffar Kazmi
KZ Kai Zhang
CW Craig B. Wilen
TH Tamas L. Horvath
IP Isabelle Plu
SH Stephane Haik
JT Jean-Leon Thomas
AL Angeliki Louvi
SF Shelli F. Farhadian
AH Anita Huttner
DS Danielle Seilhean
NR Nicolas Renier
KB Kaya Bilguvar
AI Akiko Iwasaki
request Request a Protocol
ask Ask a question
Favorite

Animals were anaesthetized using a mixture of ketamine (50 mg/kg) and xylazine (5 mg/kg) injected i.p. After sterilization of the scalp with alcohol and betadine, a midline scalp incision was made to expose the coronal and sagittal sutures, and a burr holes were drilled 1 mm lateral to the sagittal suture and 0.5 mm posterior to the bregma. A 10-µl Hamilton syringe loaded with virus and inserted into the burr hole at a depth of 2 mm from the surface of the brain and left to equilibrate for 1 min before infusion. Once the infusion was finished, the syringe was left in place for another minute before removal. Bone wax was used to fill the burr hole, and skin was stapled and cleaned. Following intramuscular administration of analgesic (meloxicam and buprenorphine, 1 mg/kg), animals were placed in a heated cage until full recovery. For the high condition, 5 µl of SARS-CoV-2 (3 × 107 PFU/ml) was used, and for the low condition, 5 µl of SARS-CoV-2 (3 × 106 PFU/ml).

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A